Skip to content

Ultrasound-guided knee nerve block in the treatment of knee osteoarthritis: a randomized controlled trial using either alone or in combination with ozone

Ultrasound-guided knee nerve block in the treatment of knee osteoarthritis: a randomized controlled trial using either alone or in combination with ozone

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035155
Enrollment
Unknown
Registered
2020-08-02
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

Ozone group:30µg/ml articular cavity injection of 15ml ozone
Genicular nerve block group:Genicular nerve block 2 times
Combined use group:Ozone combined with genicular nerve block

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for knee osteoarthritis in the Guidelines for the Diagnosis and Treatment of Osteoarthritis (2018 edition); (2) Between the ages of 50 and 85 years; (3) Duration of unilateral or bilateral knee pain >= 1 month; (4) In the recent 3 months, he did not receive any invasive treatment for the knee (such as lumen injection and acupuncture treatment); (5) Volunteer to participate in this experimental study and sign the informed consent.

Exclusion criteria

Exclusion criteria: One of the following conditions can be excluded: (1) Systemic or knee joint infection; (2) Congenital malformation, neuropathy and vascular disease cause dysfunction of lower extremity; (3) Patients with severe hip, ankle and low back pain; (4) persons with mental illness; (5) With coagulation disorders, gout, connective tissue and other diseases; (6) Knee joint diseases caused by systemic diseases; (7) Ozone allergy; (8) The intervention side of the knee has a history of surgery; (9) Bleeding or turbid joint effusion.

Design outcomes

Primary

MeasureTime frame
VAS score;WOMAC score;

Secondary

MeasureTime frame
SF-36;PHQ-9;GAD-7;

Countries

China

Contacts

Public ContactXiaohong Jin

The First Affiliated Hospital of Soochow University

jinxiaohong@suda.edu.cn+86 13962163260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026